The consensus price target hints at an 118.1% upside potential for Prothena (PRTA). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings ...

Prothena Corporation plc kept at Hold after mixed phase 2 results; key phase 3 readouts expected 2029. Click for this updated ...

Prothena Corporation ( PRTA) on Friday said that its board had authorized a share repurchase plan of up to $100 million of the company’s outstanding ordinary shares. The biotechnology company said it ...

Shares of Prothena Corporation PRTA have plunged 36.8% over the past year against the industry’s 19.6% rise. The decline can be attributed to pipeline setbacks, most notably the failure and subsequent ...

On May 27, Citizens JMP lowered the firm’s price target on Prothena Corporation plc (NASDAQ:PRTA) to $29 from $78 but kept an Outperform rating on the shares. The notable price target decrease came ...

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...

Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and Prothena (PRTA). But which of these two stocks is more ...

Looking back to 95 days ago, Prothena Corp plc (NASD: PRTA) priced a 2,250,000 share secondary stock offering at $53.00 per share. Buyers in that offering made a considerable investment into the ...